Long-term results of combined chemotherapy with gemcitabine and cisplatin for metastatic urothelial carcinomas-Reference-Cited by-同舟云学术

Long-term results of combined chemotherapy with gemcitabine and cisplatin for metastatic urothelial carcinomas

Published:2010-03-26 Issue:4 Volume:15 Page:369-375
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Tanji Nozomu,Ozawa Akira,Miura Noriyoshi,Yanagihara Yutaka,Sasaki Toyokazu,Nishida Takayasu,Kikugawa Tadahiko,Ikeda Tetsuhiro,Ochi Tatsumasa,Shimamoto Kenji,Aoki Katsunori,Yokoyama Masayoshi

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-010-0069-2.pdf

Reference11 articles.

1. Saxman SB, Proper KJ, Einhorn LH et al (1997) Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J Clin Oncol 15:2564–2569

2. Bajorin DF, Dodd PM, Mazumdar M et al (1999) Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy. J Clin Oncol 17:3173–3181

3. Roth BJ, Bajorin D (1995) Advanced bladder cancer: the need to identify new agents in the post-M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin). World J Urol 153:894–900

4. von der Maase H, Hansen SW, Roberts JT et al (2000) Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol 17:3068–3077

5. Kaufman D, Raghavan D, Carducci M et al (2000) Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer. J Clin Oncol 18:1921–1927

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical gas plasma augments bladder cancer cell toxicity in preclinical models and patient-derived tumor tissues;Journal of Advanced Research;2023-05

2. Non coding RNAs as the critical factors in chemo resistance of bladder tumor cells;Diagnostic Pathology;2020-11-12

3. PREDICTIVE AND PROGNOSTIC SIGNIFICANCE OF PRE-TREATMENT LYMPHOCYTE COUNT IN PATIENTS WITH METASTATIC UROTHELIAL CARCINOMA TREATED WITH PLATINUM-BASED FIRST-LINE CHEMOTHERAPY;The Japanese Journal of Urology;2019-07-20

4. 5‑Fluorouracil‑based adjuvant chemotherapy improves the clinical outcomes of patients with lymphovascular invasion of upper urinary tract cancer and low expression of dihydropyrimidine dehydrogenase;Oncology Letters;2019-02-28

5. Silencing of ECHDC1 inhibits growth of gemcitabine‑resistant bladder cancer cells;Oncology Letters;2017-10-26